XENON PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $63.9M | $17.1M |
| FY2017 | $6.1M | $35.9M | $20.5M |
| FY2018 | $15.0M | $103.3M | $67.8M |
| FY2019 | $10.9M | $92.0M | $24.8M |
| FY2020 | — | $171.4M | $45.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $63.9M | $17.1M |
| FY2017 | $6.1M | $35.9M | $20.5M |
| FY2018 | $15.0M | $103.3M | $67.8M |
| FY2019 | $10.9M | $92.0M | $24.8M |
| FY2020 | — | $171.4M | $45.0M |